Back to News

2021 ARM Cell & Gene Meeting on the Mesa, Carlsbad, CA (USA) & Virtual

GenSight will participate to the Cell & Gene Meeting on the Mesa, a conference organized by the Alliance of Regenerative Medicine (ARM) and held live and virtually from October 12 to 14, 2021, and will host partnering meetings.

Magali Taiel, MD, Chief Medical Officer, pre-recorded a Company presentation that will be available during the conference.

 

Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France